Literature DB >> 63371

Increased plasma binding of quinidine after surgery: a preliminary report.

D Fremstad, K Bergerud, J F Haffner, P K Lunde.   

Abstract

The plasma binding of quinidine and phenytoin has been studied pre- and postoperatively in nine patients submitted to planned gastric surgery. The binding of phenytoin showed a slight and transient reduction, whilst quinidine binding was markedly increased, on average from 78.5% on the day of operation to a maximum of 87.5%, after 2-4 days. The time course of the increase was strikingly parallel to that of the concentration of certain acute phase proteins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 63371     DOI: 10.1007/BF00563081

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Spuriously low plasma propranolol concentrations resulting from blood collection methods.

Authors:  R H Cotham; D Shand
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875

2.  Changes in the concentration of unesterified fatty acids, glycerides and phospholipids in human plasma following operation.

Authors:  L B WADSTROM
Journal:  Acta Chir Scand       Date:  1959-02-28

3.  The binding of quinidine to protein fractions of normal human sera.

Authors:  O G Nilsen; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1975-05-01       Impact factor: 5.858

4.  Letter: Reduced binding of quinidine in plasma from Vacutainers.

Authors:  D Fremstad; K Bergerud
Journal:  Clin Pharmacol Ther       Date:  1976-07       Impact factor: 6.875

5.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

6.  Effect of in vivo elevation of free fatty acids on protein binding of drugs.

Authors:  R Gugler; D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

7.  Abnormal pharmacokinetics of phenytoin in a patient with uraemia.

Authors:  I Odar-Cederlöf; P Lunde; F Sjöqvist
Journal:  Lancet       Date:  1970-10-17       Impact factor: 79.321

8.  Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease.

Authors:  W D Hooper; F Bochner; M J Eadie; J H Tyrer
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

9.  Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants.

Authors:  A Rane; P K Lunde; B Jalling; S J Yaffe; F Sjöqvist
Journal:  J Pediatr       Date:  1971-05       Impact factor: 4.406

10.  Increased binding of quinidine to serum albumin and lipoproteins in anuric rats.

Authors:  O G Nilsen; D Fremstad; S Jacobsen
Journal:  Eur J Pharmacol       Date:  1975-08       Impact factor: 4.432

  10 in total
  30 in total

1.  Drug-binding proteins in liver transplant patients.

Authors:  M L Huang; R Venkataramanan; G J Burckart; R J Ptachcinski; D H Van Thiel; T E Starzl
Journal:  J Clin Pharmacol       Date:  1988-06       Impact factor: 3.126

2.  Pharmacokinetics of quinidine in male patients. A population analysis.

Authors:  C N Verme; T M Ludden; W A Clementi; S C Harris
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 3.  Drug pharmacokinetics in the postoperative period.

Authors:  J Elfstrom
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

Review 4.  Pulmonary disease and drug kinetics.

Authors:  P du Souich; A J McLean; D Lalka; S Erill; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

5.  Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.

Authors:  I Odar-Cederlof
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

6.  Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.

Authors:  J E Bredesen; P Kierulf
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

7.  Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.

Authors:  M Yasuhara; Y Hashimoto; K Okumura; R Hori; T Sakurai; C Kawai
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

Review 8.  Protein binding of cardiac glycosides in disease states.

Authors:  L Storstein
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

9.  Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid.

Authors:  J N Bruun; N Ostby; J E Bredesen; P Kierulf; P K Lunde
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

10.  Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.